---
url: https://www.servicesaustralia.gov.au/hereditary-transthyretin-amyloidosis
title: Hereditary transthyretin amyloidosis - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:46.959Z
source: servicesaustralia.gov.au
---
# Hereditary transthyretin amyloidosis

The PBS subsidises patisiran and vutrisiran for patients with hereditary transthyretin amyloidosis.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with patisiran and vutrisiran under the _National Health Act 1953_, section 100 for adult patients with hereditary transthyretin amyloidosis.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing patisiran and vutrisiran.

## Section 100 arrangements

### Patisiran and vutrisiran

These items are only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending either:

-   an approved private hospital
-   a public hospital.

These items aren’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Treatment specifics

To be eligible for initial PBS-subsidised treatment with patisiran or vutrisiran, patients must be treated by, or in consultation with, a consultant with experience in the management of amyloid disorders.

## Authority applications

### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised patisiran or vutrisiran to treat hereditary transthyretin amyloidosis can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [hereditary transthyretin amyloidosis - patisiran or vutrisiran - initial authority application form](/pb367?context=20)
-   relevant attachments.

### Applying for initial grandfather treatment

Applications for initial grandfather authority approval to prescribe PBS-subsidised vutrisiran to treat hereditary transthyretin amyloidosis can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [hereditary transthyretin amyloidosis - vutrisiran - initial grandfather authority application form](/pb369?context=20)
-   relevant attachments.

### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised patisiran or vutrisiran to treat hereditary transthyretin amyloidosis can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [hereditary transthyretin amyloidosis - patisiran or vutrisiran - continuing authority application form](/pb368?context=20)
-   relevant attachments.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
